Henrietta Ukwu, MD

Dr. Ukwu is the executive vice president and chief regulatory officer with responsibility for leading global regulatory strategy and execution as well as the quality assurance function. Dr. Ukwu joined Novavax in January 2021, bringing more than two decades of experience in regulatory affairs and quality and successfully bringing numerous products through regulatory approval. Prior to joining Novavax, Dr. Ukwu was chief regulatory officer and global head of quality and regulatory at Otsuka Pharmaceuticals, where she led the regulatory and quality organizations with a focus on compliance excellence, inspection readiness and engagement with health authorities and regulatory agencies. She previously held senior leadership roles at PPD as senior vice president and head of Global Regulatory Affairs where she had responsibilities for regulatory services across all PPD lines of business; Wyeth Pharmaceuticals, Inc.(Pfizer), where she was vice president, regulatory affairs with responsibility that spanned vaccines, biologics, and pharmaceuticals and across all regions, and at Merck & Co., Inc., as head of vaccine regulatory development, vice president of global regulatory affairs and global regulatory policy. Dr. Ukwu holds medical and surgical degrees from the University of Jos School of Medicine in Nigeria, and completed internal medicine residency at University of Tennessee, Baptist Hospital and infectious diseases fellowship at Vanderbilt University Medical Center.